No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cytarabine / administration & dosage
-
Disease Progression
-
Drug Resistance, Neoplasm
-
Fatal Outcome
-
Female
-
Granulocyte Colony-Stimulating Factor / administration & dosage
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Idarubicin / administration & dosage
-
Immunophenotyping
-
Leukemia, Mast-Cell / diagnosis
-
Leukemia, Mast-Cell / drug therapy
-
Leukemia, Mast-Cell / etiology*
-
Leukemia, Mast-Cell / pathology
-
Leukemia, Myeloid, Acute / diagnosis
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / pathology*
-
Mast Cells / pathology
-
Mutation
-
Neoplasm Proteins / analysis
-
Neoplastic Stem Cells / pathology
-
Prognosis
-
Vidarabine / administration & dosage
-
Vidarabine / analogs & derivatives
Substances
-
Neoplasm Proteins
-
Cytarabine
-
Granulocyte Colony-Stimulating Factor
-
Vidarabine
-
Idarubicin